Neurocrine Biosciences: Clinical Trials & Research Profile
Biopharma Industry (San Diego, CA) · Primary Focus: Neurology, Psychiatry, and Pain
| Clinical Trial Metric | Verified Public Record |
|---|---|
| Organization Type | Consolidated Trial Sponsor |
| Institutional Sector & Location | Biopharma Industry (San Diego, CA) |
| Primary Therapeutic Area | Neurology, Psychiatry, and Pain |
| Active Phase II & III Studies | 19 active (14 recruiting now) |
| Total Tracked Studies (2018 to 2026) | 46 (34 with California sites) |
| Completed vs Early-Stopped Studies | 17 completed / 10 stopped (21.7% stop rate) |
| Median Closed Enrollment | 81 participants |
| FDA Drugs@FDA Original Approvals | 4 all-time (3 from 2018 to 2026) |
| Physical Hospital Site Disclosure | 97.6% named hospital slots |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Neurocrine Biosciences across sibling Meru public-data platforms.
Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk